Dr Mark C Takata, MD in La Jolla, CA - Medicare General Surgery

Dr Mark C Takata, MD is a medicare enrolled "Surgery" physician in La Jolla, California. He graduated from medical school in 2001 and has 23 years of diverse experience with area of expertise as General Surgery. He is a member of the group practice Scripps Health and his current practice location is 10666 N Torrey Pines Rd, La Jolla, California. You can reach out to his office (for appointments etc.) via phone at (858) 455-9100.

Dr Mark C Takata is licensed to practice in California (license number A94975) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1346207289.

Contact Information

	Dr Mark C Takata, MD
	10666 N Torrey Pines Rd, La Jolla, CA 92037-1027
	(858) 455-9100
	Not Available

Physician's Profile

Full Name	Dr Mark C Takata
Gender	Male
Speciality	General Surgery
Experience	23 Years
Location	10666 N Torrey Pines Rd, La Jolla, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Mark C Takata graduated from medical school in 2001

NPI Data:

NPI Number: 1346207289
Provider Enumeration Date: 04/26/2006
Last Update Date: 09/05/2007

Medicare PECOS Information:

PECOS PAC ID: 4587667530
Enrollment ID: I20060814000238

Medical Identifiers

Medical identifiers for Dr Mark C Takata such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346207289	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	A94975 (California)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Scripps Green Hospital	La jolla, CA	Hospital
Scripps Memorial Hospital - Encinitas	Encinitas, CA	Hospital
Scripps Mercy Hospital	San diego, CA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Scripps Health	9234033853	1362

News Archive

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

A new study by researchers at the Stanford University School of Medicine could help pinpoint ways to counter the effects of the antibiotics-driven depletion of friendly, gut-dwelling bacteria.

New studies on personalized lung cancer treatment presented at 3rd ELCC

Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.

Toxicology is far from robust and based on flawed evidence

The science of measuring drug levels in the blood after death is far from robust and based on flawed evidence - leading to likely miscarraiges of justice and conspiracy theories, say forensic scientists in this week's BMJ.

Researchers show how increases in state and local social spending can reduce risk of dying

Income inequality and government social spending. These are hot-??button issues in this year's presidential primaries: the rich getting richer, the poor getting poorer, and the government's role in closing the gap-or not.

Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting

Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today presented an analysis from two pivotal Phase 3 trials (REDUCE-1 and REDUCE-2) evaluating its lead investigational compound HZT-501, a combination of ibuprofen with high-dose famotidine.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mark C Takata allows following entities to bill medicare on his behalf.

Entity Name	Scripps Health
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822

News Archive

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

A new study by researchers at the Stanford University School of Medicine could help pinpoint ways to counter the effects of the antibiotics-driven depletion of friendly, gut-dwelling bacteria.

New studies on personalized lung cancer treatment presented at 3rd ELCC

Toxicology is far from robust and based on flawed evidence

Researchers show how increases in state and local social spending can reduce risk of dying

Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark C Takata is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark C Takata, MD File 54433, Los Angeles, CA 90074-0001 Ph: () -	Dr Mark C Takata, MD 10666 N Torrey Pines Rd, La Jolla, CA 92037-1027 Ph: (858) 455-9100

News Archive

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

A new study by researchers at the Stanford University School of Medicine could help pinpoint ways to counter the effects of the antibiotics-driven depletion of friendly, gut-dwelling bacteria.

New studies on personalized lung cancer treatment presented at 3rd ELCC

Toxicology is far from robust and based on flawed evidence

Researchers show how increases in state and local social spending can reduce risk of dying

Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting

Surgery Doctors in La Jolla, CA

Dr. Howard Takiff, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 760 La Canada St, La Jolla, CA 92037 Phone: 949-981-4018
Mahmoud Malas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9434 Medical Center Dr Fl 1, La Jolla, CA 92037 Phone: 619-543-6980 Fax: 858-657-5033
Cheryl Lorraine Olson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 660, La Jolla, CA 92037 Phone: 858-452-5054 Fax: 858-452-5097
James G. Schwendig, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, Lj-601, La Jolla, CA 92037 Phone: 858-626-6350 Fax: 858-626-6354
Angeles Baquerizo, Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # 200n, La Jolla, CA 92037 Phone: 858-544-4310
Dr. David Alexander Frankel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8988
Ayemoethu Ma, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # Ms 213, La Jolla, CA 92037 Phone: 858-554-8984 Fax: 858-554-5055

Dr Mark C Takata, MD - Medicare General Surgery in La Jolla, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

New studies on personalized lung cancer treatment presented at 3rd ELCC

Toxicology is far from robust and based on flawed evidence

Researchers show how increases in state and local social spending can reduce risk of dying

Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting

Medicare Reassignments

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

New studies on personalized lung cancer treatment presented at 3rd ELCC

Toxicology is far from robust and based on flawed evidence

Researchers show how increases in state and local social spending can reduce risk of dying

Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Researchers pinpoint ways to counter effects of antibiotics-driven depletion of gut-dwelling bacteria

New studies on personalized lung cancer treatment presented at 3rd ELCC

Toxicology is far from robust and based on flawed evidence

Researchers show how increases in state and local social spending can reduce risk of dying

Phase 3 trial results of Horizon Therapeutics's HZT-501 presented at the ACG meeting

Surgery Doctors in La Jolla, CA